Concepedia

Mark Jesky

MJ

19

Publications

884

Citations

17

H-Index

2012

Active since

Affiliations

University of Birmingham(Current)

Queen Elizabeth Hospital Birmingham

Nordic Bioscience (Denmark)

University College London

NIHR Surgical Reconstruction and Microbiology Research Centre

Mark Jesky is an author at University of Birmingham specializing in chronic kidney disease, nephrology, and medicine.

Top concepts

Publications per year

2012–2024

19

Publications

19

High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial

Colin A. Hutchison, Paul Cockwell, V. V. Moroz et al. · The Lancet Haematology · 2019 · 113 citations

, , +11

Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study

Mark Jesky, Mary Ann Dutton, Indranil Dasgupta et al. · PLoS ONE · 2016 · 93 citations · Full text

Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease

Cristina Beltrami, Kate Simpson, Mark Jesky et al. · American Journal Of Pathology · 2018 · 88 citations · Full text

, , +9

Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease

Anthony Fenton, Mark Jesky, Charles J. Ferro et al. · PLoS ONE · 2017 · 76 citations · Full text

Urinary endotrophin predicts disease progression in patients with chronic kidney disease

Daniel Guldager Kring Rasmussen, Anthony Fenton, Mark Jesky et al. · Scientific Reports · 2017 · 69 citations · Full text

Rows per page

1–5 of 19